Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

UVB-induced decrease of p16/CDKN2A expression in skin cancer patients.

G Krähn1, U Leiter, M Udart

  • 1Department of Dermatology, University of Munich, Germany. ulrike.leiter@medizin.uni-ulm.de

Pigment Cell Research
|July 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international study.

ESMO open·2024
Same author

Exploring 'decision regret' in adjuvant-treated melanoma patients: Results from a cross-sectional survey on 200 participants.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Improved patient safety with a simplified operating room to pediatric intensive care unit handover tool (PATHQS).

Frontiers in pediatrics·2024
Same author

Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study.

Cancer immunology, immunotherapy : CII·2021
Same author

What is new in the 2020 British guidelines for cutaneous squamous cell carcinoma?

The British journal of dermatology·2021
Same journal

Abstracts of the 4th International Melanoma Congress. November 1-4, 2007.

Pigment cell research·2007
Same journal

ATF2 on the double - activating transcription factor and DNA damage response protein.

Pigment cell research·2007
Same journal

Cutaneous melanoma in genetically modified animals.

Pigment cell research·2007
Same journal

DNA microarray analyses of melanoma gene expression: a decade in the mines.

Pigment cell research·2007
Same journal

The many faces of Notch signaling in skin-derived cells.

Pigment cell research·2007
Same journal

Melanoma, making a difference.

Pigment cell research·2007
See all related articles

UVB exposure down-regulates p16/CDKN2A gene expression in skin cancer patients, unlike healthy individuals. This decline in p16/CDKN2A may impair cell cycle regulation, offering insights into UV-induced skin cancer development.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Cancer Research

Background:

  • p16 expression in melanoma tissues is contradictory.
  • Ultraviolet (UV) radiation, including UVB, impacts p16 expression and cell cycle regulation.
  • p16/CDKN2A is a key tumor suppressor gene involved in cell cycle control.

Purpose of the Study:

  • To investigate the effect of UVB exposure on p16/CDKN2A gene expression in skin cancer patients and healthy individuals.
  • To explore the role of p16/CDKN2A down-regulation in UV-induced skin carcinogenesis.

Main Methods:

  • Reverse transcription polymerase chain reaction (RT-PCR) was used to quantify p16/CDKN2A gene expression.
  • Participants included skin cancer patients, a dysplastic nevus patient, and healthy controls.

Related Experiment Videos

  • Samples were analyzed before and after controlled UVB exposure (one minimal erythema dose).

    • Main Results:

    • Five out of seven skin cancer patients exhibited down-regulation of p16/CDKN2A expression post-UVB exposure.
    • Healthy individuals and the dysplastic nevus patient showed no significant alteration in p16/CDKN2A expression after UVB.
    • UVB-induced decline in p16/CDKN2A was observed specifically in skin cancer patients.

    Conclusions:

    • UVB-induced down-regulation of p16/CDKN2A in skin cancer patients suggests a potential mechanism in photocarcinogenesis.
    • Impaired cell cycle regulation due to decreased p16/CDKN2A may contribute to skin cancer development.
    • Altered p16/CDKN2A expression patterns after UVB exposure could serve as a biomarker for identifying individuals at higher risk of UV-induced skin cancer.